5 reports

  • 4.3 MOLECULAR TARGETS IN THE PIPELINE

Immunotherapy; ##(##): ##-##.

  • Infectious Disease
  • Pharmaceutical
  • Therapy
  • Tuberculosis
  • GlaxoSmithKline plc
  • Tuberculosis Vaccines - Pipeline Products (Company and Stages)

Increase in the growth of this segment globally has been due to Tuberculosis (TB) being one of the top ## causes of death worldwide.

  • Tuberculosis
  • Vaccine
  • World
  • Market Size
  • GlaxoSmithKline plc

Introduction TB is an infectious disease caused by the bacterium, Mycobacterium tuberculosis.

  • Diagnostics
  • Tuberculosis
  • World
  • Market Size
  • Alere Inc.
  • Infectex Enters Into Licensing Agreement With Qurient For Tuberculosis Drug Q203
  • Jun 22, 2017: Infectex Successfully Completes Phase 1 Clinical Study of Q203 for Treatment of Tuberculosis

" Q## is undergoing intensive phase ## testing and demonstrates excellent results in all studies, including one that is completed by our partner Infectex", - said Dr.

  • Healthcare
  • Pharmaceutical
  • Tuberculosis
  • South Korea
  • Qurient Co., Ltd.
  • August 2016

Q. ##.

  • Diagnostics
  • Healthcare
  • Molecular Diagnostics
  • Tuberculosis
  • Alere Inc.